TARDBP and amyotrophic lateral sclerosis: Hosokawa et al. reported that TDP-43 concentrations in CSF were significantly higher in ALS than in Guillain-Barré syndrome (GBS), which suggested that quantitative measurement of CSF TDP-43 levels is a potential laboratory testing for differentiating ALS from peripheral neuropathies (14).